John McLaughlin - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
John McLaughlin has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
John McLaughlin holds the role of Director at Sonoma Pharmaceuticals, Inc. (SNOA). McLaughlin has reported 3 insider filings with the SEC since 2026. The most recent filing was in July 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- Sonoma Pharmaceuticals, Inc.
Reported roles
- Director
Awards & honors
- Director of Sonoma Pharmaceuticals, Inc. per SEC filing (CIK 0001203240).
- No securities transactions reported in the filing (Total purchases $0, Total sales $0).
- Active in corporate governance as a member of the board.
Trading Pattern
InsiderAlpha's records for John McLaughlin go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role John McLaughlin has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at Sonoma Pharmaceuticals, Inc. (SNOA) - 2 filings, 2026
Companies - Last 90 Days
- Sonoma Pharmaceuticals, Inc. (SNOA) - 1 filing, last 2026-07-10
Most Active Insiders Right Now
John McLaughlin has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Marc Johnson
- James Jones
- Andrew T. Kaplan
- A. J. Kazimi
- Michael John Kazley
- Kennedy Lewis Investment Holdings II LLC
- KENNEDY LEWIS MANAGEMENT LP
- James M. Kilts
Frequently Asked Questions
Who is John McLaughlin?
John McLaughlin holds the role of Director at Sonoma Pharmaceuticals, Inc. (SNOA). McLaughlin has reported 3 insider filings with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has John McLaughlin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of John McLaughlin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live John McLaughlin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.